CLINICAL TRIALS AND OBSERVATIONS Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
نویسندگان
چکیده
1C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Fondazione Istituti di ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan; 2Chair of Medical Oncology, University of Milan, Milan; and 3Human Tumor Immunobiology Unit, 4Molecular Targeting Unit, and 5Pathology Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma
Idiotype vaccination for follicular lymphoma is primarily being developed as remission consolidation after chemotherapy. We investigated idiotype vaccination as primary intervention for treatmentnaive indolent B-cell lymphoma and in a separate cohort as remission consolidation after chemotherapy to assess immunization-induced immune responses in relation to progression-free survival (German Cli...
متن کاملRegular Article CLINICAL TRIALS AND OBSERVATIONS Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
Follicular lymphoma (FL) is the most common subtype of indolent non-Hodgkin lymphoma and is often diagnosed in advanced stage. Although immunotherapy with anti-CD20 monoclonal antibodies has had a major impact on the prognosis in FL over the past 10 to 15 years, most patients eventually relapse and die of their disease. Therapeutic vaccines targeting the immunoglobulin idiotype in FL initially ...
متن کاملIdiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
In this issue of Clinical Cancer Research , Hansson et al. vaccinated 28 patients (IgG myeloma, Salmon-Durie stages I and II) with autologous myeloma idiotype protein and assessed the effect of adding either granulocyte macrophage colonystimulating factor (GM-CSF) alone or the combination of GMCSF and interleukin 12 (IL-12) during the vaccination program (1). Idiotype-specific T-cell responses ...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
Second-line chemotherapy followed by high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) cures less than half of the patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Prognostic models capable of predicting outcome are essential. In 3 sequential clinical trials, conducted from January 1993 to August 2000, we treated 150 patients with relapsed or pr...
متن کاملCLINICAL TRIALS AND OBSERVATIONS The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
Given the significant activity and tolerability of bendamustine, rituximab, and bortezomib in patients with relapsed indolent and mantle cell non-Hodgkin lymphoma, and laboratory studies suggesting synergistic activity, we conducted a multicenter phase 2 study of the bendamustine/ bortezomib/rituximab combination. Patients with relapsed or refractory indolent and mantle cell lymphoma with adequ...
متن کامل